top of page
Search

Lupin Ltd

  • Writer: Bapan Acharjee
    Bapan Acharjee
  • Jan 1
  • 1 min read

Updated: Aug 19


ree

Lupin Ltd is a 56-year-old pharma company managed by Manju D Gupta (Non-Executive Chairman), Nilesh D Gupta (MD), Vinita Gupta (CEO), and Ramesh Swaminathan (ED & Global CFO) and they have 22,000 plus employees, 1,000 plus products and 15 Global facilities. Spread in more than 100 countries, their products are Antiviral drugs, Pharmaceutical drugs, Animal Health, Dietary supplements, Protein supplements, Contact lenses, etc. Lupin launched its IPO in 2002 at the face value of Rs. 13.63 and the company has shown 175.81% growth in the last 5 years. However, their revenue is 20,142 crore and their net profit is 1,936 crore for FY 2023-24.

Comments

Subscribe for latest updates • Don’t miss out!

Our Details

© 2035 by Unsold 70

Build a future-ready portfolio with Unsold70

Here is a Gateway of becoming a smart and informed stock market investor. At Unsold70, we bring you powerful stock market basics and a selected list of best 70 companies that are worth investing in. No matter you are a beginner or an experienced investor, our research-driven stock market news helps you uncover undervalued stocks with high growth potential.

 

Our team analyzes the trends, financials, and market movements to provide clear, actionable advice for confident investing. If you have the question how to invest in stock market in your mind, stay ahead with our expert updates, performance tracking, and real-time stock signals.

 

We refine our top 70 list regularly as per the recent stock market changes. Hence, we try to help the investors building a strong, stable, and future-ready portfolio. The right picks today can shape your financial success tomorrow. Explore smarter ways to invest and grow your wealth.

bottom of page